Epilepsy, characterized by recurrent seizures, is a neurological disorder with significant psychiatric implications. From mood disturbances to cognitive challenges, understanding the broader impact of epilepsy is crucial. The Journal of Clinical Psychiatry provides comprehensive insights into the psychiatric aspects of epilepsy, offering evidence-based therapeutic approaches and the latest research findings. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care to individuals with epilepsy.
Epilepsy
Recently published articles about Epilepsy
Case Report
Mesial Temporal Sclerosis and Juvenile Myoclonic Epilepsy
March 26, 2026
The authors present a rare case of coexisting right mesial temporal sclerosis and juvenile myoclonic epilepsy, underscoring the challenges in dual epilepsy syndromes and the importance of individualized, multidisciplinary...
Case Report
ECT for Catatonia With NPSLE, Epilepsy, and Cerebral Palsy
July 25, 2024
An 18-year-old patient with neuropsychiatric systemic lupus erythematosus, epilepsy, and cerebral palsy who developed benzodiazepine-refractory catatonia and immunosuppression experienced complete resolution of symptoms after 20 ECT treatments.
Clinical and Practical Psychopharmacology
Epilepsy, Antiepileptic Drugs, and Adverse Pregnancy Outcomes, 2: Major Congenital Malformations
July 3, 2024
This article reviews evidence from a large registry, a population-based study, and a meta-analysis on the risks of major congenital malformation with untreated epilepsy and with exposure to antiepileptic...
Clinical and Practical Psychopharmacology
Epilepsy, Antiepileptic Drugs, and Adverse Pregnancy Outcomes, 1: Recent Research
June 5, 2024
This article provides women who have epilepsy and who use antiepileptic drugs during pregnancy with information about the many risks to which they and their fetus/neonate are exposed at...
Recent JCP Articles on Epilepsy
Rounds in the General Hospital
Medical Traumatic Stress and Medical Posttraumatic Stress Disorder Following Illness and Treatment: What Primary Care Providers Need to Know
November 12, 2026
Medical PTSD has been associated with debilitating mental health symptoms and a decreased quality of life, as well as with worse medical outcomes.
Expert Commentary
DT120 for Generalized Anxiety Disorder: Findings From Phase 2b and Phase III Trials
November 11, 2026
Lori Davis, MD, reviews clinical trial findings on DT120, an oral disintegrating tablet formulation of lysergide, for generalized anxiety disorder. She describes efficacy findings across a phase 2b trial...
Recent PCC Articles on Epilepsy
Expert Commentary
Challenges in Psychedelic Research Trials for Anxiety and Mood Disorders
November 11, 2026
Lori Davis, MD, of the University of Alabama at Birmingham describes methodological and clinical challenges in psychedelic research trials for anxiety and mood disorders. She discusses functional unblinding, expectancy...
